These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3424441)

  • 21. [The chromosomal HLA region].
    Degos L
    Pathol Biol (Paris); 1986 Jun; 34(6):707-10. PubMed ID: 3531985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assessment of secondary disease based on HLA expression in the plasma of an allogeneic bone marrow recipient].
    Zotnikov EA; Vasiĺeva MN; Poreshina LP; Kutina RM; Golovkina LL; Liubimov LS; Mendeleeva LP; Savchenko VG
    Biull Eksp Biol Med; 1995 Dec; 120(12):596-8. PubMed ID: 8834210
    [No Abstract]   [Full Text] [Related]  

  • 23. Side effects induced by gold drugs: a graft-versus-host-like disease.
    Verwilghen J; Pope RM; Panayi GS
    J Lab Clin Med; 1994 May; 123(5):777-80. PubMed ID: 8195684
    [No Abstract]   [Full Text] [Related]  

  • 24. Individual variation in alloresponsiveness and the molecular basis of allorecognition.
    Batchelor JR; Kaminski E; Lombardi G; Goldman JM; Lechler RI
    Hum Immunol; 1990 Jun; 28(2):96-103. PubMed ID: 2141014
    [No Abstract]   [Full Text] [Related]  

  • 25. The genetics of HLA.
    Schwartz DW; Felser B; Mayr WR
    Folia Biol (Praha); 1995; 41(3-4):123-39. PubMed ID: 7589710
    [No Abstract]   [Full Text] [Related]  

  • 26. [HLA and transfusion].
    Wittmann G; Zimmermann R; Eckstein R
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):207-12. PubMed ID: 7919910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects.
    Stelljes M; Specht C; Albring J; Volkmann S; Schlösser V; Pauels HG; Poremba C; Bisping G; Opitz C; Scheffold C; Silling G; Kiehl M; Berdel WE; Kienast J
    Transplantation; 2007 Feb; 83(3):314-22. PubMed ID: 17297406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation.
    Smyth LA; Witt CS; Christiansen FT; Herrmann RP; Hollingsworth PN; Townend DC; Edward E; Dawkins RL
    Bone Marrow Transplant; 1993 Oct; 12(4):351-5. PubMed ID: 8275034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of HLA in bone marrow transplantation].
    Harada M; Mori T; Matsuda T
    Rinsho Ketsueki; 1985 Dec; 26(12):1927-35. PubMed ID: 3914558
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of anti-non-MHC-directed T cell reactivity following in vivo priming after HLA-identical marrow transplantation and following in vitro priming in limiting dilution cultures.
    Irlé C; Chapuis B; Jeannet M; Kaestli M; Montandon N; Speck B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2674-7. PubMed ID: 3547946
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human leukocyte antigen genes and allergic disease.
    Howell WM; Holgate ST
    Monogr Allergy; 1996; 33():53-70. PubMed ID: 8930926
    [No Abstract]   [Full Text] [Related]  

  • 33. GVHD pathophysiology: is acute different from chronic?
    Toubai T; Sun Y; Reddy P
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):101-17. PubMed ID: 18503979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease.
    Tutschka PJ; Berkowitz SD; Tuttle S; Klein J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2668-73. PubMed ID: 3547945
    [No Abstract]   [Full Text] [Related]  

  • 35. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody.
    Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG
    Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1994 Dec; 153(11):4959-68. PubMed ID: 7963559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limiting dilution analysis of human IL-2 producing T-cell precursors. Determination of hierarchical alloantigenic potential of human leukocyte antigens and evaluation of alloimune responses to single HLA-DP molecules.
    Jeras M; Delbosc A; Bohinjec M; Tongio MM
    Pflugers Arch; 2000; 439(3 Suppl):R104-6. PubMed ID: 10653157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of HLA chimerism].
    Kuwata S
    Nihon Rinsho; 1999 Nov; 57 Suppl():705-8. PubMed ID: 10635951
    [No Abstract]   [Full Text] [Related]  

  • 39. [HLA polymorphism: the origin of individual response in immunity].
    Takata H; Uchiyama T; Inoko H
    Tanpakushitsu Kakusan Koso; 1996 Nov; 41(15 Suppl):2355-68. PubMed ID: 8952398
    [No Abstract]   [Full Text] [Related]  

  • 40. Human keratinocytes expressing HLA class II induce short-term anergy toward alloantigens.
    van Dijk AM; Otten HG; Ververs C; de Boer M; Verdonck LF; de Gast GC
    Transplant Proc; 1997; 29(1-2):1027-8. PubMed ID: 9123181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.